238 related articles for article (PubMed ID: 15254735)
1. Truncation of the mismatch repair protein PMS2 during the neoplastic transformation of human breast epithelial cells in vitro.
Balogh GA; Russo IH; Russo J
Int J Oncol; 2004 Aug; 25(2):381-7. PubMed ID: 15254735
[TBL] [Abstract][Full Text] [Related]
2. The mismatch repair gene hPMS2 is mutated in primary breast cancer.
Balogh GA; Heulings RC; Russo J
Int J Mol Med; 2006 Nov; 18(5):853-7. PubMed ID: 17016615
[TBL] [Abstract][Full Text] [Related]
3. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.
Balogh GA; Russo IH; Russo J
Int J Oncol; 2003 Aug; 23(2):411-9. PubMed ID: 12851690
[TBL] [Abstract][Full Text] [Related]
4. Conditional nuclear localization of hMLH3 suggests a minor activity in mismatch repair and supports its role as a low-risk gene in HNPCC.
Korhonen MK; Raevaara TE; Lohi H; Nyström M
Oncol Rep; 2007 Feb; 17(2):351-4. PubMed ID: 17203173
[TBL] [Abstract][Full Text] [Related]
5. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
[TBL] [Abstract][Full Text] [Related]
6. The E705K mutation in hPMS2 exerts recessive, not dominant, effects on mismatch repair.
Deschênes SM; Tomer G; Nguyen M; Erdeniz N; Juba NC; Sepúlveda N; Pisani JE; Liskay RM
Cancer Lett; 2007 May; 249(2):148-56. PubMed ID: 17029773
[TBL] [Abstract][Full Text] [Related]
7. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
8. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
9. A novel function of protein kinase B as an inducer of the mismatch repair gene hPMS2 degradation.
Jia J; Zhang Y; Cai J; Wang J; Ding H; Zhou J; Fang F; Wang Z
Cell Signal; 2013 Jun; 25(6):1498-504. PubMed ID: 23499907
[TBL] [Abstract][Full Text] [Related]
10. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.
Liu T; Yan H; Kuismanen S; Percesepe A; Bisgaard ML; Pedroni M; Benatti P; Kinzler KW; Vogelstein B; Ponz de Leon M; Peltomäki P; Lindblom A
Cancer Res; 2001 Nov; 61(21):7798-802. PubMed ID: 11691795
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance.
Gibson SL; Narayanan L; Hegan DC; Buermeyer AB; Liskay RM; Glazer PM
Cancer Lett; 2006 Dec; 244(2):195-202. PubMed ID: 16426742
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of human mismatch repair genes in adult T-cell leukemia.
Morimoto H; Tsukada J; Kominato Y; Tanaka Y
Am J Hematol; 2005 Feb; 78(2):100-7. PubMed ID: 15682421
[TBL] [Abstract][Full Text] [Related]
13. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
Yeh CC; Lee C; Dahiya R
Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
[TBL] [Abstract][Full Text] [Related]
14. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction.
Wei Q; Guan Y; Cheng L; Radinsky R; Bar-Eli M; Tsan R; Li L; Legerski RJ
Pathobiology; 1997; 65(6):293-300. PubMed ID: 9491849
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability.
Ma AH; Xia L; Littman SJ; Swinler S; Lader G; Polinkovsky A; Olechnowicz J; Kasturi L; Lutterbaugh J; Modrich P; Veigl ML; Markowitz SD; Sedwick WD
Oncogene; 2000 Apr; 19(18):2249-56. PubMed ID: 10822375
[TBL] [Abstract][Full Text] [Related]
16. Mismatch repair and microsatellite instability in esophageal cancer cells.
Uchida N; Kumimoto H; Nishizawa K; Tokumasu S; Harada H; Shimada Y; Ishizaki K
Int J Cancer; 2001 Mar; 91(5):687-91. PubMed ID: 11267981
[TBL] [Abstract][Full Text] [Related]
17. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.
Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB
DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176
[TBL] [Abstract][Full Text] [Related]
18. Loss of mismatch repair activity in simian virus 40 large T antigen-immortalized BPH-1 human prostatic epithelial cell line.
Yeh CC; Lee C; Huang MC; Dahiya R
Mol Carcinog; 2001 Jul; 31(3):145-51. PubMed ID: 11479923
[TBL] [Abstract][Full Text] [Related]
19. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
20. DNA mismatch repair protein expression and microsatellite instability in primary mucosal melanomas of the head and neck.
Marani C; Alvino E; Caporali S; Vigili MG; Mancini G; Rahimi S
Histopathology; 2007 May; 50(6):780-8. PubMed ID: 17493242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]